These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 23440243)

  • 21. GATA1 and cooperating mutations in myeloid leukaemia of Down syndrome.
    Garnett C; Cruz Hernandez D; Vyas P
    IUBMB Life; 2020 Jan; 72(1):119-130. PubMed ID: 31769932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leukemogenesis in infants and young children with trisomy 21.
    Roberts I
    Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):1-8. PubMed ID: 36485097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biology and management of transient abnormal myelopoiesis (TAM) in children with Down syndrome.
    Roy A; Roberts I; Vyas P
    Semin Fetal Neonatal Med; 2012 Aug; 17(4):196-201. PubMed ID: 22421527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Genetic heterogeneity in transient abnormal myelopoiesis].
    Saida S
    Rinsho Ketsueki; 2015 Dec; 56(12):2434-40. PubMed ID: 26725351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modeling Down Syndrome Myeloid Leukemia by Sequential Introduction of
    Barwe SP; Sebastian A; Sidhu I; Kolb EA; Gopalakrishnapillai A
    Cells; 2022 Feb; 11(4):. PubMed ID: 35203280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The landscape of somatic mutations in Down syndrome-related myeloid disorders.
    Yoshida K; Toki T; Okuno Y; Kanezaki R; Shiraishi Y; Sato-Otsubo A; Sanada M; Park MJ; Terui K; Suzuki H; Kon A; Nagata Y; Sato Y; Wang R; Shiba N; Chiba K; Tanaka H; Hama A; Muramatsu H; Hasegawa D; Nakamura K; Kanegane H; Tsukamoto K; Adachi S; Kawakami K; Kato K; Nishimura R; Izraeli S; Hayashi Y; Miyano S; Kojima S; Ito E; Ogawa S
    Nat Genet; 2013 Nov; 45(11):1293-9. PubMed ID: 24056718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Abnormal hematopoiesis in Down syndrome].
    Ito E
    Rinsho Ketsueki; 2014 Oct; 55(10):1738-47. PubMed ID: 25297735
    [No Abstract]   [Full Text] [Related]  

  • 28. Enigma of myeloid proliferation in Down syndrome.
    Hasegawa D
    Pediatr Int; 2019 Mar; 61(3):221. PubMed ID: 30916856
    [No Abstract]   [Full Text] [Related]  

  • 29. Synergistic roles of DYRK1A and GATA1 in trisomy 21 megakaryopoiesis.
    Sit YT; Takasaki K; An HH; Xiao Y; Hurtz C; Gearhart PA; Zhang Z; Gadue P; French DL; Chou ST
    JCI Insight; 2023 Oct; 8(23):. PubMed ID: 37906251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Placental Pathology in Down Syndrome-Associated Transient Abnormal Myelopoiesis.
    Kuo E; Kumarapeli AR
    Arch Pathol Lab Med; 2020 Mar; 144(3):388-393. PubMed ID: 30969155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Down syndrome-associated haematopoiesis abnormalities created by chromosome transfer and genome editing technologies.
    Kazuki Y; Yakura Y; Abe S; Osaki M; Kajitani N; Kazuki K; Takehara S; Honma K; Suemori H; Yamazaki S; Sakuma T; Toki T; Shimizu R; Nakauchi H; Yamamoto T; Oshimura M
    Sci Rep; 2014 Aug; 4():6136. PubMed ID: 25159877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of Full-Length GATA1 Expression in Megakaryocytes Is a Sensitive and Specific Immunohistochemical Marker for the Diagnosis of Myeloid Proliferative Disorder Related to Down Syndrome.
    Lee WY; Weinberg OK; Evans AG; Pinkus GS
    Am J Clin Pathol; 2018 Mar; 149(4):300-309. PubMed ID: 29481579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evolution of myeloid leukemia in children with Down syndrome.
    Saida S
    Int J Hematol; 2016 Apr; 103(4):365-72. PubMed ID: 26910243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The paradox of Myeloid Leukemia associated with Down syndrome.
    Gupte A; Al-Antary ET; Edwards H; Ravindranath Y; Ge Y; Taub JW
    Biochem Pharmacol; 2022 Jul; 201():115046. PubMed ID: 35483417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A neonate with a unique non-Down syndrome transient proliferative megakaryoblastic disease.
    Bertrums EJ; Buijs A; van Grotel M; Dors N; de Rooij JD; de Haas V; Hopman S; Jongmans MC; Zwaan CM; van den Heuvel-Eibrink MM
    Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27667142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms of Progression of Myeloid Preleukemia to Transformed Myeloid Leukemia in Children with Down Syndrome.
    Labuhn M; Perkins K; Matzk S; Varghese L; Garnett C; Papaemmanuil E; Metzner M; Kennedy A; Amstislavskiy V; Risch T; Bhayadia R; Samulowski D; Hernandez DC; Stoilova B; Iotchkova V; Oppermann U; Scheer C; Yoshida K; Schwarzer A; Taub JW; Crispino JD; Weiss MJ; Hayashi Y; Taga T; Ito E; Ogawa S; Reinhardt D; Yaspo ML; Campbell PJ; Roberts I; Constantinescu SN; Vyas P; Heckl D; Klusmann JH
    Cancer Cell; 2019 Aug; 36(2):123-138.e10. PubMed ID: 31303423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prenatal diagnosis of transient abnormal myelopoiesis in three fetuses with Down syndrome: heterogeneous ultrasonographic findings and outcomes.
    Rizzo A; Perotti G; Fiandrino G; Spinillo A; Stronati M; Iasci A
    Ultrasound Obstet Gynecol; 2018 Mar; 51(3):412-413. PubMed ID: 28600809
    [No Abstract]   [Full Text] [Related]  

  • 38. Physical association of the patient-specific GATA1 mutants with RUNX1 in acute megakaryoblastic leukemia accompanying Down syndrome.
    Xu G; Kanezaki R; Toki T; Watanabe S; Takahashi Y; Terui K; Kitabayashi I; Ito E
    Leukemia; 2006 Jun; 20(6):1002-8. PubMed ID: 16628190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Down syndrome and GATA1 mutations in transient abnormal myeloproliferative disorder: mutation classes correlate with progression to myeloid leukemia.
    Kanezaki R; Toki T; Terui K; Xu G; Wang R; Shimada A; Hama A; Kanegane H; Kawakami K; Endo M; Hasegawa D; Kogawa K; Adachi S; Ikeda Y; Iwamoto S; Taga T; Kosaka Y; Kojima S; Hayashi Y; Ito E
    Blood; 2010 Nov; 116(22):4631-8. PubMed ID: 20729467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transient abnormal myelopoiesis in neonates: GATA get the diagnosis.
    Bombery M; Vergilio JA
    Arch Pathol Lab Med; 2014 Oct; 138(10):1302-6. PubMed ID: 25268193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.